Insider Trading Alert - AIRM, CLB And CSGP Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, March 10, 2014, 109 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $50.96 to $374,999,999.94.

Highlighted Stocks Traded by Insiders:

Air Methods (AIRM) - FREE Research Report

Gordon Crystal L who is General Counsel and Secretary at Air Methods sold 4,895 shares at $54.18 on March 10, 2014. Following this transaction, the General Counsel and Secretary owned 16,604 shares meaning that the stake was reduced by 22.77% with the 4,895-share transaction.

The shares most recently traded at $54.42, up $0.24, or 0.44% since the insider transaction. Historical insider transactions for Air Methods go as follows:

  • 4-Week # shares sold: 54,996
  • 12-Week # shares sold: 54,996
  • 24-Week # shares sold: 69,350

The average volume for Air Methods has been 354,500 shares per day over the past 30 days. Air Methods has a market cap of $2.2 billion and is part of the health care sector and health services industry. Shares are down 5.53% year-to-date as of the close of trading on Friday.

Air Methods Corporation, together with its subsidiaries, provides air medical emergency transport services and systems in the United States. The company operates in two segments, Air Medical Services (AMS) and United Rotorcraft (UR). The company has a P/E ratio of 35.7. Currently there are 5 analysts that rate Air Methods a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on AIRM - FREE

TheStreet Quant Ratings rates Air Methods as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Air Methods Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Core Laboratories N.V (CLB) - FREE Research Report

Kearney Michael C who is Director at Core Laboratories N.V sold 2,000 shares at $193.00 on March 10, 2014. Following this transaction, the Director owned 10,361 shares meaning that the stake was reduced by 16.18% with the 2,000-share transaction.

The shares most recently traded at $193.52, up $0.52, or 0.27% since the insider transaction. Historical insider transactions for Core Laboratories N.V go as follows:

  • 4-Week # shares bought: 400
  • 4-Week # shares sold: 1,500
  • 12-Week # shares bought: 400
  • 12-Week # shares sold: 1,500
  • 24-Week # shares bought: 400
  • 24-Week # shares sold: 7,204

The average volume for Core Laboratories N.V has been 263,600 shares per day over the past 30 days. Core Laboratories N.V has a market cap of $8.7 billion and is part of the basic materials sector and energy industry. Shares are up 1.16% year-to-date as of the close of trading on Friday.

Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the oil and gas industry in the Netherlands and internationally. The company operates in three segments: Reservoir Description, Production Enhancement, and Reservoir Management. The stock currently has a dividend yield of 1.04%. The company has a P/E ratio of 36.6. Currently there are 3 analysts that rate Core Laboratories N.V a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CLB - FREE

TheStreet Quant Ratings rates Core Laboratories N.V as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, impressive record of earnings per share growth and increase in net income. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Core Laboratories N.V Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

CoStar Group (CSGP) - FREE Research Report

Florance Andrew C who is President and CEO at CoStar Group sold 50,000 shares at $210.04 on March 10, 2014. Following this transaction, the President and CEO owned 187,443 shares meaning that the stake was reduced by 21.06% with the 50,000-share transaction.

The shares most recently traded at $208.93, down $1.11, or 0.53% since the insider transaction. Historical insider transactions for CoStar Group go as follows:

  • 4-Week # shares sold: 8,500
  • 12-Week # shares sold: 8,500
  • 24-Week # shares sold: 9,048

The average volume for CoStar Group has been 159,300 shares per day over the past 30 days. CoStar Group has a market cap of $6.1 billion and is part of the financial sector and real estate industry. Shares are up 14.42% year-to-date as of the close of trading on Friday.

CoStar Group, Inc. provides information, analytics, and marketing services to the commercial real estate industry in the United States, the United Kingdom, and France. The company has a P/E ratio of 201.1. Currently there are 4 analysts that rate CoStar Group a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CSGP - FREE

TheStreet Quant Ratings rates CoStar Group as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, robust revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full CoStar Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists